• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌性TPM3-ALK激活需要通过TPM3的卷曲螺旋结构进行二聚化。

Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.

作者信息

Amano Yosuke, Ishikawa Rie, Sakatani Toshio, Ichinose Junji, Sunohara Mitsuhiro, Watanabe Kousuke, Kage Hidenori, Nakajima Jun, Nagase Takahide, Ohishi Nobuya, Takai Daiya

机构信息

Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Department of Cardiothoracic Surgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

出版信息

Biochem Biophys Res Commun. 2015 Feb 13;457(3):457-60. doi: 10.1016/j.bbrc.2015.01.014. Epub 2015 Jan 14.

DOI:10.1016/j.bbrc.2015.01.014
PMID:25596129
Abstract

Inflammatory myofibroblastic tumor (IMT) is a mesenchymal tumor that can arise from anywhere in the body. Anaplastic lymphoma kinase (ALK) gene rearrangements, most often resulting in the tropomyosin 3 (TPM3)-ALK fusion gene, are the main causes of IMT. However, the mechanism of malignant transformation in IMT has yet to be elucidated. The purpose of this study was to clarify the role of the TPM3 region in the transformation of IMT via TPM3-ALK. Lentivirus vectors containing a TPM3-ALK fusion gene lacking various lengths of TPM3 were constructed and expressed in HEK293T and NIH3T3 cell lines. Focus formation assay revealed loss of contact inhibition in NIH3T3 cells transfected with full-length TPM3-ALK, but not with ALK alone. Blue-native polyacrylamide gel electrophoresis (BN-PAGE) revealed that TPM3-ALK dimerization increased in proportion to the length of TPM3. Western blot showed phosphorylation of ALK, ERK1/2, and STAT3 in HEK293T cells transfected with TPM3-ALK. Thus, the coiled-coil structure of TPM3 contributes to the transforming ability of the TPM3-ALK fusion protein, and longer TPM3 region leads to higher dimer formation.

摘要

炎性肌纤维母细胞瘤(IMT)是一种间叶性肿瘤,可发生于身体的任何部位。间变性淋巴瘤激酶(ALK)基因重排,最常见的是导致原肌球蛋白3(TPM3)-ALK融合基因,是IMT的主要病因。然而,IMT恶性转化的机制尚未阐明。本研究的目的是阐明TPM3区域在IMT通过TPM3-ALK转化中的作用。构建了含有缺失不同长度TPM3的TPM3-ALK融合基因的慢病毒载体,并在HEK293T和NIH3T3细胞系中表达。集落形成试验显示,用全长TPM3-ALK转染的NIH3T3细胞失去接触抑制,而单独用ALK转染的细胞则没有。蓝色天然聚丙烯酰胺凝胶电泳(BN-PAGE)显示,TPM3-ALK二聚化与TPM3的长度成正比增加。蛋白质免疫印迹法显示,用TPM3-ALK转染的HEK293T细胞中ALK、ERK1/2和STAT3发生磷酸化。因此,TPM3的卷曲螺旋结构有助于TPM3-ALK融合蛋白的转化能力,且TPM3区域越长,二聚体形成越高。

相似文献

1
Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.致癌性TPM3-ALK激活需要通过TPM3的卷曲螺旋结构进行二聚化。
Biochem Biophys Res Commun. 2015 Feb 13;457(3):457-60. doi: 10.1016/j.bbrc.2015.01.014. Epub 2015 Jan 14.
2
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.炎症性肌纤维母细胞瘤中的TPM3-ALK和TPM4-ALK致癌基因。
Am J Pathol. 2000 Aug;157(2):377-84. doi: 10.1016/S0002-9440(10)64550-6.
3
TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.TPM3-ALK表达可诱导细胞骨架组织发生变化,并赋予比其他ALK融合蛋白更高的转移能力。
Eur J Cancer. 2007 Mar;43(4):640-6. doi: 10.1016/j.ejca.2006.12.005. Epub 2007 Feb 2.
4
Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.伴有间变性大细胞淋巴瘤激酶融合基因的炎性肌纤维母细胞瘤中无人类疱疹病毒8型和EB病毒。
Pathol Int. 2006 Oct;56(10):584-90. doi: 10.1111/j.1440-1827.2006.02012.x.
5
Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.TPM3-ALK阳性间变性大细胞淋巴瘤的基因表达谱分析揭示了与NPM-ALK阳性间变性大细胞淋巴瘤重叠和独特的模式。
Leuk Res. 2008 Mar;32(3):383-93. doi: 10.1016/j.leukres.2007.07.012. Epub 2007 Aug 27.
6
Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins.编码嵌合间变性淋巴瘤激酶融合蛋白的致癌性染色体易位伙伴的蛋白质组学鉴定。
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7402-7. doi: 10.1073/pnas.0506514103. Epub 2006 May 1.
7
ALK-positive anaplastic large cell lymphoma with TPM3-ALK translocation.伴有TPM3-ALK易位的ALK阳性间变性大细胞淋巴瘤
Leuk Res. 2012 Jul;36(7):e143-5. doi: 10.1016/j.leukres.2012.04.008. Epub 2012 May 14.
8
Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.表达新型融合蛋白 PPFIBP1-ALK 的肺炎性肌纤维母细胞瘤:重新评估抗 ALK 免疫组化作为新型 ALK 融合鉴定工具。
Clin Cancer Res. 2011 May 15;17(10):3341-8. doi: 10.1158/1078-0432.CCR-11-0063. Epub 2011 Mar 23.
9
Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.开发用于TPM3-ALK诱导肿瘤发生的条件性生物发光移植模型,作为验证ALK依赖性癌症靶向治疗的工具。
Cancer Biol Ther. 2007 Aug;6(8):1318-23. doi: 10.4161/cbt.6.8.4508. Epub 2007 May 29.
10
Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.炎症性肌纤维母细胞瘤中ALK与Ran结合蛋白2(RANBP2)基因的融合。
Genes Chromosomes Cancer. 2003 May;37(1):98-105. doi: 10.1002/gcc.10177.

引用本文的文献

1
, a novel rearrangement in lung squamous cell carcinoma and its clinical responses to ALK inhibitors.肺鳞状细胞癌中的一种新型重排及其对ALK抑制剂的临床反应。
J Thorac Dis. 2025 Jan 24;17(1):93-108. doi: 10.21037/jtd-24-1428. Epub 2025 Jan 21.
2
Mechanisms of tropomyosin 3 in the development of malignant tumors.原肌球蛋白3在恶性肿瘤发生发展中的作用机制
Heliyon. 2024 Aug 2;10(15):e35723. doi: 10.1016/j.heliyon.2024.e35723. eCollection 2024 Aug 15.
3
Updates in pathobiological aspects of anaplastic large cell lymphoma.间变性大细胞淋巴瘤病理生物学方面的进展
Front Oncol. 2023 Sep 22;13:1241532. doi: 10.3389/fonc.2023.1241532. eCollection 2023.
4
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via expression.ALK 融合 NSCLC 癌基因通过表达促进存活并抑制 NK 细胞反应。
Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2216479120. doi: 10.1073/pnas.2216479120. Epub 2023 Feb 15.
5
Lung adenocarcinoma with an uncommon CCDC85A-ALK fusion responding to alectinib: A case report.肺腺癌伴不常见的 CCDC85A-ALK 融合,对阿来替尼有反应:一例报告。
J Cell Mol Med. 2022 Oct;26(20):5326-5329. doi: 10.1111/jcmm.17520. Epub 2022 Sep 14.
6
Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.新型TENM3-ALK融合是神经母细胞瘤中ALK激活的另一种机制。
Oncogene. 2022 May;41(20):2789-2797. doi: 10.1038/s41388-022-02301-1. Epub 2022 Apr 11.
7
The prognostic value of TPM1-4 in hepatocellular carcinoma.TPM1-4 在肝细胞癌中的预后价值。
Cancer Med. 2022 Jan;11(2):433-446. doi: 10.1002/cam4.4453. Epub 2021 Nov 30.
8
Nicotine promotes the development of oral leukoplakia via regulating peroxiredoxin 1 and its binding proteins.尼古丁通过调节过氧化物酶 1 及其结合蛋白促进口腔白斑的发展。
Braz J Med Biol Res. 2021 May 31;54(9):e10931. doi: 10.1590/1414-431X2020e10931. eCollection 2021.
9
Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in -Rearranged Non-small Cell Lung Cancers.ALK融合蛋白单体化作为间变性大细胞淋巴瘤相关非小细胞肺癌的一种治疗策略
Front Oncol. 2020 Apr 2;10:419. doi: 10.3389/fonc.2020.00419. eCollection 2020.
10
ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.成人肾细胞癌中的ALK-TPM3重排:一例报告及文献综述
Diagn Pathol. 2019 Oct 18;14(1):112. doi: 10.1186/s13000-019-0879-0.